Citations

Showing 10 of 108094 citations.

Cardiac Arrest in a Vitamin D–Deficient Infant
Creo, Ana L. , Tebben, Peter J. , Thacher, Thomas D., Pittock, Siobhán T. , Fischer, Philip R. , Tebben, Peter

Mayo Clinic

Global Pediatric Health | March 20, 2018 | Volume: 5 | Issue: No issue available | Pages: No page available

10.1177/2333794x18765064 | PMID 29581997 Get It

Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization
Shirafuji, Norimichi, Hamano, Tadanori , Yen, Shu-Hui, Kanaan, Nicholas M. , Yoshida, Hirotaka , Hayashi, Kouji, Ikawa, Masamichi , Yamamura, Osamu , Kuriyama, Masaru, Nakamoto, Yasunari

Mayo Clinic

International Journal of Molecular Sciences | March 20, 2018 | Volume: 19 | Issue: 3 | Pages: 891

10.3390/ijms19030891 | PMID 29562600 Get It

Increased plasma homocysteinemia is considered a risk factor of dementia, including Alzheimer’s disease (AD) and vascular dementia. However, the reason elevated plasma homocysteinemia increases the risk of dementia remains unknown. A pathological hallmark of AD is neurofibrillary tangles (NFTs) that consist of pathologically phosphorylated tau proteins. The effect of homocysteine (Hcy) on tau aggregation was explored using human neuroblastoma M1C cells that constitutively express human wild-type tau (4R0N) under the control of a tetracycline off system, primary mouse cultured neurons, and by inducing hyperhomocysteinemia in a mouse model of tauopathy (HHCy mice). A wide range of Hcy concentrations (10–1000 µM) increased total tau and phosphorylated tau protein levels. Hcy activated glycogen synthase kinase 3, and cyclin dependent kinase 5, major tau phosphokinases, and inactivated protein phosphatase 2A, a main tau phosphatase. Hcy exhibited cytotoxic effects associated with enhanced activation of caspase. Truncation of tau in the C-terminus, the cleavage site of caspase 3 (i.e., D421, detected by the TauC3 antibody) was also increased. Total tau, phosphorylated tau, as well as C-terminal cleaved tau were increased in the sarkosyl insoluble tau fraction. Hcy also increased the level of tau oligomers, as indicated by the tau oligomer complex 1 (TOC1) antibody that specifically identifies oligomeric tau species, in the tris insoluble, sarkosyl soluble fraction. The levels of TOC1-positive oligomeric tau were increased in brain lysates from HHCy mice, and treating HHCy mice with S-adenosylmethionine, an intermediate of Hcy, reduced the levels of oligomeric tau to control levels. These observations suggest that Hcy increases the levels of phosphorylated tau as well as truncated tau species via caspase 3 activation, and enhanced tau oligomerization and aggregation.
Review: Adding a DPP-4 inhibitor to an SGLT-2 inhibitor reduces genital, but not genitourinary, tract infections
Rodríguez-Gutiérrez, René , Montori, Víctor M.

Mayo Clinic

Annals of Internal Medicine | March 19, 2018 | Volume: 168 | Issue: 6 | Pages: JC33

10.7326/acpjc-2018-168-6-033 | PMID 29554671 Get It

Successful Outcomes at Midterm Follow-up of Periacetabular Osteotomy Done for Mild Hip Dysplasia
Potter, Guy D., Novais, Eduardo N. , Trousdale, Robert T. , Sierra, Rafael J.

Mayo Clinic

The Journal of Hip Surgery | March 19, 2018 | Volume: 01 | Issue: 04 | Pages: 167-172

10.1055/s-0038-1635102 Get It

AbstractYoung hip surgeons are often faced with the decision to either perform arthroscopic surgery or a periacetabular osteotomy (PAO) in patients with symptomatic mild hip dysplasia (MHD). There is, however, a paucity of data on the results of PAO in this group. The aim of this paper is to report the results of PAOs in patients with MHD and compare those to hips with more severe forms of hip dysplasia (SHD). This data can then be used to compare emerging data reporting the results of hip arthroscopy for MHD. From January, 1996 to May, 2009, 299 hips in 268 patients were identified that underwent PAO at one institution. After removing those with <2 years of follow-up, 182 hips were followed up. The average age of the cohort was 31 years, and 85% were female. Nineteen hips with lateral center edge (LCE) angle from 18 to 25° and a Tönnis angle (TA) between 10 and 15° were considered to have MHD. This group was compared with the rest of the cohort (SHD). The mean clinical follow-up for the MHD group was 121 months. There was no significant difference in demographic variables between the groups. There were no complications in the MHD cohort. Surgical correction resulted in significant improvements in all radiographic measurements consistent with hip dysplasia in both groups. The Harris Hip Score (HHS) improved significantly in both groups ([MHD: 52–92] [SHD: 66–89]). Two hips (10.5%) in the MHD group and 15 hips (9.2%) in the SHD group underwent future THA (p = 0.69). The survivorship free from THA was 100%, 100%, and 86% at 3, 5, and 10 years, respectively, in the MHD group. The corresponding rates for hips in the control group at 3, 5, and 10 years, respectively, were 99%, 95%, and 81%. PAO in patients with MHD provides predictable improvements in pain, function, and results that are durable and comparable to hips with SHD. This data should be used to compare the early and midterm results of arthroscopic surgery performed in mildly dysplastic hips.
Does Greater Trochanter Decortication Affect Suture Anchor Pullout Strength in Abductor Tendon Repairs? A Biomechanical Study
Putnam, Jill G. , Castañeda, Paulo , Walker, J. Brock , Barber, Collin C., Lendrum, James, Hartigan, David E. , Chhabra, Anikar

Mayo Clinic

The American Journal of Sports Medicine | March 19, 2018 | Volume: 46 | Issue: 7 | Pages: 1668-1673

10.1177/0363546518759033 | PMID 29554437 Get It

Background: Greater trochanter decortication is frequently performed at the time of abductor tendon repair to theoretically increase healing potential. No previous studies have determined the effect that greater trochanter decortication has on the pullout strength of suture anchors. Hypothesis/Purpose: The purpose of this study is to determine whether greater trochanter decortication and bone mineral density affect suture anchor pullout strength in abductor tendon repair. The authors hypothesize that both will have a significant detrimental effect on suture anchor pullout strength. Study Design: Controlled laboratory study. Methods: Nineteen cadaveric proximal femurs with accompanying demographic data and computed tomography scans were skeletonized to expose the greater trochanter. Bone density measurements were acquired by converting Hounsfield units to T-score, based on a standardized volumetric sample in the intertrochanteric region of the femur. The gluteus medius insertion site on the lateral facet of the greater trochanter was evenly divided into 2 regions, anterior-distal and posterior-proximal, and each region was randomly assigned to receive either no decortication or 2 mm of bone decortication. A single biocomposite anchor was implanted in each region and initially tested with cyclic loading for 10 cycles at 0-50 N, 0-100 N, 0-150 N, and 0-200 N, followed by load to failure (LTF) tested at 1 mm/s. For each trial, the number of cycles endured, LTF, mechanism of failure, and stiffness were recorded. Results: Greater trochanters with no decortication and 2 mm of decortication survived a mean ± SD 35.1 ± 6.4 and 28.5 ± 10.6 cycles, respectively ( P < .01). Load to failure for nondecorticated specimens was 206.7 ± 75.0 N versus 152.3 ± 60.2 N for decorticated specimens ( P < .001). In a multivariate analysis, decortication and bone density were determinants in LTF ( P < .05). Conclusion: Decortication and decreased bone mineral density significantly decreased the pullout strength of suture anchors in the lateral facet of the greater trochanter. Clinical Relevance: Bone density should be considered when determining whether to perform greater trochanter decortication in abductor tendon repairs.
Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer Screening
Resnick, Matthew J., Graves, Amy J., Thapa, Sunita, Gambrel, Robert, Tyson, Mark D. , Buntin, Melinda Beeuwkes, Penson, David F. , Lee, Daniel

Mayo Clinic

JAMA Internal Medicine | March 19, 2018 | Volume: 178 | Issue: 5 | Pages: 648

10.1001/jamainternmed.2017.8087 | PMID 29554179 Get It

Skill sets for family members and friends to help motivate a smoker to seek treatment: research to practice
Patten, Christi A. , Lukowski, Amy V., Brockman, Tabetha A. , Patten, Christi

Mayo Clinic

Addiction Research & Theory | March 19, 2018 | Volume: 26 | Issue: 6 | Pages: 525-532

10.1080/16066359.2018.1450872 | PMID 31787862 Get It

P1218Incidence and Risk Factors for Renal Dysfunction after Direct Current Cardioversion of Atrial Fibrillation
Grüner‐Hegge, Nicolai, Padmanabhan, Deepak , Mehta, Rajesh , Hodge, D, Meludini, R, Rihal, C., Mulpuru, Siva K. , Deshmukh, Abhishek , Ammash, Naser M., Greene, Eddie L., Friedman, Paul A. , Kella, Danesh , Mehta, R, Hodge, D

Mayo Clinic

EP Europace | March 19, 2018 | Volume: 20 | Issue: suppl_1 | Pages: i239-i239

10.1093/europace/euy015.700 Get It

119Antiarrythmia Device use in Myotonic Dystrophy population: A Single Center Experience
Grüner‐Hegge, Nicolai, Padmanabhan, D, Hodge, D.O., Prado, J.J., Aguayo, Rolando Vega, Friedman, Paul J., Kella, Danesh

Mayo Clinic

EP Europace | March 19, 2018 | Volume: 20 | Issue: suppl_1 | Pages: i17-i17

10.1093/europace/euy015.041 Get It

P927Venoplasty to facilitate transvenous lead placement: a single-center experience
Padmanabhan, D, Mulpuru, Siva K. , Cha, Y, Friedman, Paul A. , Kella, Danesh

Mayo Clinic

EP Europace | March 19, 2018 | Volume: 20 | Issue: suppl_1 | Pages: i181-i181

10.1093/europace/euy015.528 Get It